Marcello Di Nisio Selected Research

Marcello Di Nisio Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 05/2004
45	Hemorrhage 01/2022 - 02/2012
35	Venous Thromboembolism 02/2022 - 05/2004
23	Thrombosis (Thrombus) 01/2022 - 11/2009
8	Disseminated Intravascular Coagulation 07/2020 - 05/2012
8	Sepsis (Septicemia) 07/2020 - 05/2012
8	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 12/2003
7	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2021 - 01/2018
6	COVID-19 10/2022 - 11/2020
5	Pulmonary Embolism 10/2019 - 06/2011
5	Thrombophilia 01/2018 - 12/2003
4	Pneumonia (Pneumonitis) 10/2022 - 11/2020
4	Cognitive Dysfunction 01/2019 - 09/2014
4	Pain (Aches) 11/2015 - 09/2012
3	Atrial Fibrillation 02/2022 - 09/2014
3	Inflammation (Inflammations) 01/2022 - 10/2004
3	Body Weight (Weight, Body) 05/2021 - 09/2016
3	Multiple Myeloma 12/2020 - 08/2014
3	Dementia (Dementias) 01/2019 - 11/2018
3	Thrombophlebitis 12/2018 - 02/2014
3	Weight Loss (Weight Reduction) 07/2004 - 09/2002
2	Myocardial Infarction 02/2022 - 06/2014
2	Critical Illness (Critically Ill) 02/2022 - 01/2013
2	Upper Extremity Deep Vein Thrombosis 01/2022 - 12/2016
2	Infections 01/2022 - 01/2020
2	Lung Neoplasms (Lung Cancer) 10/2020 - 11/2010
2	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 05/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 05/2011
2	Hypertension (High Blood Pressure) 01/2017 - 09/2002
2	Vomiting 06/2015 - 09/2012
2	Nausea 06/2015 - 09/2012
2	Habitual Abortion (Recurrent Miscarriage) 07/2014 - 01/2009
2	Spontaneous Abortion (Miscarriage) 07/2014 - 01/2009
2	Vascular Remodeling 10/2004 - 06/2002
2	Atherosclerosis 10/2004 - 06/2002
2	Obesity 01/2004 - 09/2002
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Ischemic Stroke 01/2022
1	Heart Failure 01/2022
1	Pericarditis 01/2022
1	Thromboembolism 10/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2021
1	Thrombocytopenia (Thrombopenia) 05/2021
1	Brain Neoplasms (Brain Tumor) 05/2021
1	Disease Progression 11/2020

Drug/Important Bio-Agent (IBA)

40	AnticoagulantsIBA 02/2022 - 03/2005
29	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 05/2004
14	Vitamin K FDA Link 01/2022 - 05/2004
11	edoxabanIBA 02/2022 - 11/2015
11	Heparin (Liquaemin)FDA LinkGeneric 12/2020 - 03/2005
9	RivaroxabanIBA 02/2022 - 10/2015
8	AntithrombinsIBA 12/2020 - 02/2012
8	Dacarbazine (DIC)FDA LinkGeneric 07/2020 - 05/2012
7	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 01/2018
7	Warfarin (Coumadin)FDA LinkGeneric 12/2020 - 02/2012
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2020 - 01/2007
6	Fondaparinux (Arixtra)FDA Link 01/2021 - 03/2012
6	Factor Xa InhibitorsIBA 12/2020 - 08/2014
5	Enoxaparin (Lovenox)FDA LinkGeneric 01/2022 - 01/2009
5	fibrin fragment D (D-dimer)IBA 09/2020 - 04/2014
4	tocilizumab (atlizumab)FDA Link 10/2022 - 11/2020
4	apixabanIBA 02/2022 - 08/2014
4	CytokinesIBA 01/2021 - 06/2002
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 06/2011
3	Pharmaceutical PreparationsIBA 02/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 07/2018 - 03/2016
3	LeptinIBA 07/2004 - 09/2002
2	Dexamethasone (Maxidex)FDA LinkGeneric 02/2022 - 01/2021
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 11/2005
2	ThrombomodulinIBA 01/2020 - 09/2016
2	Biological ProductsIBA 01/2020 - 09/2002
2	Vitamin B Complex (B Vitamins)IBA 12/2018 - 11/2018
2	Vitamin E FDA LinkGeneric 12/2018 - 11/2018
2	MineralsIBA 12/2018 - 11/2018
2	VitaminsIBA 12/2018 - 11/2018
2	vinyltriethoxysilane (VTES)IBA 12/2018 - 02/2014
2	semuloparinIBA 12/2016 - 08/2014
2	Nadroparin (Nadroparin Calcium)IBA 07/2014 - 05/2011
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2004 - 09/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2004 - 06/2002
1	InflammasomesIBA 01/2022
1	Colchicine FDA LinkGeneric 01/2022
1	betrixabanIBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	ORALIT (ORS)IBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 12/2021
1	cyclo(Arg-Pro) (CI 4)IBA 07/2021
1	Oxygen (Dioxygen)IBA 11/2020

Therapy/Procedure

32	Therapeutics 02/2022 - 05/2004
18	Drug Therapy (Chemotherapy) 12/2021 - 11/2010
4	Duration of Therapy 08/2018 - 06/2011
3	Contraindications 11/2020 - 01/2013
2	Catheters 05/2021 - 11/2015
2	Operative Surgical Procedures 01/2021 - 02/2019
2	Central Venous Catheters 12/2016 - 03/2016
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2016 - 08/2015
2	Caloric Restriction 01/2004 - 09/2002
1	Indwelling Catheters (Indwelling Catheter) 01/2022